citric acid, anhydrous has been researched along with hirudin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 16 (47.06) | 18.2507 |
| 2000's | 7 (20.59) | 29.6817 |
| 2010's | 9 (26.47) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Karlberg, KE; Sylvén, C | 1 |
| Fernández, JA; Griffin, JH; Gruber, A | 1 |
| Glusa, E | 2 |
| Fareed, J; Hoppensteadt, D; Kaiser, B; Markwardt, F; Walenga, JM | 1 |
| Braun, B; Heiden, M; Koehler, M; Pindur, G; Wenzel, E | 1 |
| Basic-Micic, M; Breddin, HK; Rauschenbach, C | 1 |
| Bell, DN; Goldsmith, HL; Spain, S | 1 |
| Glusa, E; Markwardt, F | 1 |
| Friedberg, RC; Hagen, PO; Pizzo, SV | 1 |
| Beumer, S; de Groot, PG; IJsseldijk, MJ; Sixma, JJ | 1 |
| Bretschneider, E; Glusa, E; Schrör, K | 1 |
| Basic-Micic, M; Breddin, HK | 1 |
| Bowry, SK; Courtney, JM; Gaylor, JD; Lowe, GD; Matata, BM; Sundaram, S; Vienken, J; Wark, S | 1 |
| Małyszko, J; Małyszko, JS; Myśliwiec, M | 1 |
| Engstad, CS; Gutteberg, TJ; Osterud, B | 1 |
| Albert, J; Bröijersén, A; Ladjevardi, M; Wallén, NH | 1 |
| Belcher, PR; Chaudhry, MA; Day, SP; Menys, VC; Muriithi, EW; Raco, L; Wheatley, DJ | 1 |
| Hjemdahl, P; Li, N; Wallén, NH; Yngen, M | 1 |
| Casserly, IP; Gibson, PH; Gray, WA; Kereiakes, DJ; Lauer, MA; Moliterno, DJ; Reginelli, JP | 1 |
| Heptinstall, S; May, JA | 1 |
| Rai, AJ; Vitzthum, F | 1 |
| Kalb, ML; Kozek-Langenecker, SA; Potura, L; Scharbert, G | 1 |
| Bouman, HJ; Hackeng, CM; Pittens, CA; ten Berg, JM; van Werkum, JW | 1 |
| Baumgarten, A; Kalbantner, K; Mischke, R | 1 |
| Kim, MH; Yu, LH; Zhang, HZ | 1 |
| Kristensen, AT; Marschner, CB; Spodsberg, EH; Wiinberg, B | 1 |
| Hakimi, CS; Jeppsson, A; Karlsson, M; Roman-Emanuel, C; Thimour-Bergström, L | 1 |
| Ecob, R; Joshi, RR; Judge, HM; Morton, AC; Storey, RF; Sumaya, W | 1 |
| Azimi-Nezhad, M; Betsou, F; Chapel, C; Gaillard, G; Lambert, D; Masson, C; Meyronet, D; Ottone, C; Perrin, C; Pfister, M; Siest, SV; Tabone, E; Ungeheuer, MN | 1 |
| Caudell, DL; Cline, JM; Dugan, G; Hanbury, DB; O'Donnell, L | 1 |
| Barenholz, Y; Cedrone, E; Clogston, JD; Dobrovolskaia, MA; McNeil, SE; Neun, BW; Rodriguez, J; Szebeni, J; Vermilya, A | 1 |
| Johswich, KO; Strobel, L | 1 |
| Hvas, AM; Nissen, PH; Skipper, MT | 1 |
3 review(s) available for citric acid, anhydrous and hirudin
| Article | Year |
|---|---|
Hirudin and platelets.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium Chloride; Citrates; Citric Acid; Collagen; Epinephrine; Hirudins; Humans; Platelet Adhesiveness; Platelet Aggregation; Recombinant Fusion Proteins; Serotonin; Thrombin; Thromboxane A2 | 1991 |
[Anticoagulants in hemodialysis therapy].
Topics: Anticoagulants; Citrates; Citric Acid; Epoprostenol; Fibrinolytic Agents; Heparin; Hirudins; Humans; Platelet Aggregation Inhibitors; Renal Dialysis | 1996 |
Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
Topics: Anticoagulants; Artifacts; Autoanalysis; Blood Proteins; Chemical Fractionation; Citric Acid; Edetic Acid; Heparin; Hirudins; Humans; Pathology, Clinical; Patient Compliance; Peptides; Plasma; Proteomics; Specimen Handling | 2006 |
2 trial(s) available for citric acid, anhydrous and hirudin
| Article | Year |
|---|---|
Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
Topics: Adult; Anticoagulants; Blood Coagulation Tests; Blood Platelets; Citrates; Citric Acid; Female; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1993 |
Modulation of blood cell activation by four commonly used anticoagulants.
Topics: Anticoagulants; Citric Acid; Drug Evaluation; Edetic Acid; Heparin; Hirudins; Humans; Lipopolysaccharides; Monocytes; Neutrophil Activation; Platelet Activation; Reference Values | 1997 |
29 other study(ies) available for citric acid, anhydrous and hirudin
| Article | Year |
|---|---|
Heparin enhances platelet aggregation irrespective of anticoagulation with citrate or with hirudin.
Topics: Adult; Calcium; Citrates; Citric Acid; Collagen; Dose-Response Relationship, Drug; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Platelet Aggregation; Recombinant Proteins | 1992 |
Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin.
Topics: Anticoagulants; Carrier Proteins; Citrates; Citric Acid; Complement Inactivator Proteins; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Hirudins; Humans; Immunosorbent Techniques; Male; Molecular Weight; Partial Thromboplastin Time; Protein Binding; Protein S; Reference Values | 1992 |
In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
Topics: Blood Coagulation; Blood Coagulation Tests; Citrates; Citric Acid; Dose-Response Relationship, Drug; Heparin; Hirudins; Humans; Peptide Fragments; Prothrombin; Recombinant Proteins; Thrombin | 1991 |
Hirudin--a potential stabilizing factor for platelet preservation in transfusion.
Topics: beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Blood Preservation; Citric Acid; Evaluation Studies as Topic; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Glucose; Hirudins; Humans; Platelet Factor 4; Plateletpheresis; Recombinant Proteins; Secretory Rate | 1991 |
The effects of recombinant hirudin on various platelet functions.
Topics: Adenosine Diphosphate; Blood Platelets; Citrates; Citric Acid; Epinephrine; Heparin; Hirudins; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Recombinant Proteins | 1991 |
Platelet aggregation in recombinant-hirudin-anticoagulated blood.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Citrates; Citric Acid; Collagen; Drug Synergism; Epinephrine; Hirudins; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Serotonin | 1991 |
Extracellular-free Ca++ accounts for the sex difference in the aggregation of human platelets in citrated platelet-rich plasma.
Topics: Anticoagulants; Calcium; Citrates; Citric Acid; Extracellular Space; Female; Heparin; Hirudins; Humans; Male; Platelet Aggregation; Sex Factors | 1990 |
Platelet functions in recombinant hirudin-anticoagulated blood.
Topics: Anticoagulants; Blood Platelets; Citrates; Citric Acid; Heparin; Hirudins; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Serotonin; Thrombin | 1990 |
The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin.
Topics: Animals; Antithrombin III; Aorta; Calcium; Cattle; Cell Line; Citrates; Citric Acid; Endothelium, Vascular; Factor Xa; Hirudins; Humans; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 1988 |
Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Citrates; Citric Acid; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Fibronectins; Glass; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Molecular Sequence Data; Oligopeptides; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Receptors, Fibronectin; Stress, Mechanical; Surface Properties; Thrombasthenia; Umbilical Veins | 1994 |
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Calcium; Citric Acid; Collagen; Epinephrine; Glucose; Hirudins; Humans; Indomethacin; Phenylacetates; Platelet Activating Factor; Platelet Aggregation; Receptors, Thromboxane; Recombinant Proteins; Sulfonamides; Thromboxanes | 1994 |
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents.
Topics: Anticoagulants; Aprotinin; Binding, Competitive; Cellulose; Citrates; Citric Acid; Dalteparin; Factor XII; Fibrinolytic Agents; Hemostatics; Heparin; Hirudins; In Vitro Techniques; Membranes, Artificial; Molecular Weight; Nylons; Recombinant Proteins; Renal Dialysis; Surface Properties | 1995 |
Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin.
Topics: Anticoagulants; Citric Acid; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hirudins; Humans; Platelet Aggregation | 1997 |
Quantitative detection of platelet aggregates in whole blood without fixation.
Topics: Adult; Aged; Anticoagulants; Blood Physiological Phenomena; Citric Acid; Coronary Artery Bypass; Edetic Acid; Female; Fixatives; Glutaral; Heparin; Hirudins; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Time Factors | 2000 |
Insulin enhances platelet activation in vitro.
Topics: Adult; Anticoagulants; Blood; Citric Acid; Dose-Response Relationship, Drug; Flow Cytometry; Hirudins; Humans; Insulin; Male; Platelet Activation; Platelet Count | 2001 |
Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Topics: Aged; Blood Coagulation Tests; Citric Acid; Drug Monitoring; Endopeptidases; Female; Fibrinolytic Agents; Hirudins; Humans; Male; Peptide Fragments; Point-of-Care Systems; Recombinant Proteins | 2004 |
Effects of anticoagulants used during blood collection on human platelet function.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Anticoagulants; Blood Platelets; Citric Acid; Female; Heparin; Hirudins; Humans; Membrane Proteins; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pregnancy; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Time Factors | 2004 |
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
Topics: Adenosine Diphosphate; Anticoagulants; Arachidonic Acid; Arginine; Azetidines; Benzylamines; Blood Platelets; Citric Acid; Collagen; Female; Heparin; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Function Tests; Recombinant Proteins; Ristocetin; Sulfonamides; Time Factors | 2009 |
Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests.
Topics: Adult; Citric Acid; Coronary Artery Disease; Drug Monitoring; Female; Hirudins; Humans; Male; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Young Adult | 2009 |
Measurement of platelet function in dogs using a novel impedance aggregometer.
Topics: Adenosine Diphosphate; Animals; Anticoagulants; Arachidonic Acid; Blood Platelets; Citric Acid; Collagen; Dogs; Electric Impedance; Female; Hirudins; Male; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Anticoagulants; Arachidonic Acid; Aspirin; Citric Acid; Clopidogrel; Female; Hirudins; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; ROC Curve; Sensitivity and Specificity; Stents; Ticlopidine | 2013 |
Evaluation of platelet aggregometry in dogs using the Multiplate platelet analyzer: impact of anticoagulant choice and assay duration.
Topics: Animals; Anticoagulants; Citric Acid; Dogs; Female; Heparin; Hirudins; Male; Platelet Aggregation; Platelet Function Tests; Time Factors | 2012 |
Sampling conditions influence multiple electrode platelet aggregometry in cardiac surgery patients.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Blood Specimen Collection; Citric Acid; Coronary Artery Bypass; Electrodes; Female; Fibrinolytic Agents; Hemostatics; Heparin; Heparin Antagonists; Hirudins; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Postoperative Care; Postoperative Hemorrhage; Predictive Value of Tests; Preoperative Care; Prospective Studies; Protamines; Sensitivity and Specificity; Thrombin; Time Factors | 2013 |
Stability of VerifyNow P2Y12 assay results with citrate anticoagulation as compared to hirudin anticoagulation over 20-min period.
Topics: Anticoagulants; Blood Platelets; Citric Acid; Hirudins; Humans; Platelet Function Tests; Receptors, Purinergic P2Y12 | 2015 |
Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations.
Topics: Anticoagulants; Citric Acid; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Freezing; Gene Expression; Glucose; Hirudins; Humans; Leukocytes, Mononuclear; Muscle, Skeletal; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specimen Handling; Temperature; Time Factors; Vascular Endothelial Growth Factor A | 2012 |
Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques.
Topics: Animals; Anticoagulants; Area Under Curve; Blood Platelets; Citric Acid; Collagen; Fibrinolytic Agents; Heparin; Hirudins; Macaca mulatta; Male; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Sensitivity and Specificity | 2015 |
Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations.
Topics: Anticoagulants; Blood Coagulation; Cell Proliferation; Citric Acid; Complement Activation; Cytokines; Drug Compounding; Edetic Acid; Heparin; Hirudins; Humans; Leukocytes; Liposomes; Nanoparticles; Particle Size; Platelet Aggregation; Surface Properties | 2017 |
Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection.
Topics: Animals; Anticoagulants; Bacterial Outer Membrane Proteins; Blood Cells; Carrier Proteins; Citric Acid; Complement Activation; Heparin; Hirudins; Humans; Immunity, Innate; Meningococcal Infections; Microbial Viability; Models, Biological; Neisseria meningitidis | 2018 |
Whole blood platelet aggregation determined by the ROTEM platelet equipment; reference intervals and stability.
Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Arachidonic Acid; Citric Acid; Female; Hirudins; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Receptors, Thrombin; Reference Values; Reproducibility of Results; Young Adult | 2020 |